Importer of Controlled Substances Application: Mallinckrodt LLC, 23071-23072 [2017-10242]
Download as PDF
<![CDATA[
23071
Federal Register / Vol. 82, No. 96 / Friday, May 19, 2017 / Notices
In accordance with 21 CFR
1301.33(a), this is notice that on March
7, 2017, American Radiolabeled
Chemicals, Inc., 101 Arc Drive, Saint
Louis, Missouri 63146 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
Controlled substance
Drug code
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Ibogaine ...........................................................................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ...............................................................................................................................
Dihydromorphine .............................................................................................................................................................
Heroin ..............................................................................................................................................................................
Normorphine ....................................................................................................................................................................
Amphetamine ...................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Phenylacetone .................................................................................................................................................................
Cocaine ............................................................................................................................................................................
Codeine ...........................................................................................................................................................................
Dihydrocodeine ................................................................................................................................................................
Oxycodone .......................................................................................................................................................................
Hydromorphone ...............................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Metazocine ......................................................................................................................................................................
Methadone .......................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
Morphine ..........................................................................................................................................................................
Oripavine .........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Oxymorphone ..................................................................................................................................................................
Phenazocine ....................................................................................................................................................................
Carfentanil .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to manufacture
small quantities of the listed controlled
substances as radiolabeled compounds
for biochemical research.
Dated: May 15, 2017.
Louis J. Milione,
Assistant Administrator.
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Mallinckrodt LLC
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
DATES:
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearing on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
ADDRESSES:
[FR Doc. 2017–10240 Filed 5–18–17; 8:45 am]
ACTION:
or before June 19, 2017. Such persons
may also file a written request for a
hearing on the application pursuant to
21 CFR 1301.43 on or before June 19,
2017.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispenses,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on
December 21, 2016, Mallinckrodt LLC,
3600 North Second Street, Saint Louis,
Missouri 63147 applied to be registered
as an importer of the following basic
classes of controlled substances:
Drug code
Marihuana ........................................................................................................................................................................
19:15 May 18, 2017
Jkt 241001
PO 00000
Frm 00119
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
SUPPLEMENTARY INFORMATION:
Controlled substance
VerDate Sep<11>2014
2010
7260
7315
7370
7435
7470
9145
9200
9313
1100
1105
2125
7471
8501
9041
9050
9120
9143
9150
9180
9193
9230
9240
9250
9273
9300
9330
9333
9652
9715
9743
9801
Schedule
E:\FR\FM\19MYN1.SGM
19MYN1
7360
Schedule
I
23072
Federal Register / Vol. 82, No. 96 / Friday, May 19, 2017 / Notices
Controlled substance
Drug code
Phenylacetone .................................................................................................................................................................
Coca Leaves ....................................................................................................................................................................
Opium, raw ......................................................................................................................................................................
Poppy Straw Concentrate ...............................................................................................................................................
The company plans to import the
listed controlled substances to bulk
manufacture into Active Pharmaceutical
Ingredients for distribution to its
customers. Placement of these drug
codes onto the company’s registration
does not translate into automatic
approval of subsequent permit
applications to import controlled
substances.
In reference to drug code 7360
(Marihuana) the company plans to
import a synthetic cannabidiol. No other
activity for this drug code is authorized
for this registration.
Dated: May 15, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017–10242 Filed 5–18–17; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Dated: May 10, 2017.
Andrew G. McCabe,
Acting Director.
Federal Bureau of Investigation
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Notice of Charter Reestablishment
[FR Doc. 2017–10095 Filed 5–18–17; 8:45 am]
In accordance with the provisions of
the Federal Advisory Committee Act,
Title 5, United States Code, Appendix,
and Title 41, Code of Federal
Regulations 101–6.1015, with the
concurrence of the Attorney General, I
have determined that the
reestablishment of the Criminal Justice
Information Services (CJIS) Advisory
Policy Board (APB) is in the public
interest. In connection with the
performance of duties imposed upon the
FBI by law, I hereby give notice of the
reestablishment of the APB Charter.
The APB provides me with general
policy recommendations with respect to
the philosophy, concept, and
operational principles of the various
criminal justice information systems
managed by the FBI’s CJIS Division.
The APB includes representatives
from local and state criminal justice
agencies; tribal law enforcement
representatives; members of the judicial,
prosecutorial, and correctional sectors
of the criminal justice community, as
well as one individual representing a
national security agency; a
representative of the National Crime
Prevention and Privacy Compact
Council; a representative of federal
agencies participating in the CJIS
Division Systems; and representatives of
VerDate Sep<11>2014
19:15 May 18, 2017
Jkt 241001
criminal justice professional
associations (i.e., the American
Probation and Parole Association;
American Society of Crime Laboratory
Directors; International Association of
Chiefs of Police; National District
Attorneys Association; National
Sheriffs’ Association; Major Cities
Chiefs Association; Major County
Sheriffs’ Association; and a
representative from a national
professional association representing
the courts or court administrators
nominated by the Conference of Chief
Justices). The Attorney General has
granted me the authority to appoint all
members to the APB.
The APB functions solely as an
advisory body in compliance with the
provisions of the Federal Advisory
Committee Act. The Charter has been
filed in accordance with the provisions
of the Act.
BILLING CODE 4410–02–P
DEPARTMENT OF JUSTICE
[OMB Number 1110–0058]
Agency Information Collection
Activities; Proposed Collection;
Comments Requested National
Incident-Based Reporting System
(NIBRS)
Federal Bureau of
Investigation, Department of Justice.
ACTION: 30-day notice.
AGENCY:
Department of Justice (DOJ),
Federal Bureau of Investigation,
Criminal Justice Information Services
Division will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. This proposed
information collection was previously
published in the Federal Register
allowing for a 60-day comment period.
DATES: Comments are encouraged and
will be accepted for an additional 30
days until June 19, 2017.
FOR FURTHER INFORMATION CONTACT:
Written comments and/or suggestions
SUMMARY:
PO 00000
Frm 00120
Fmt 4703
Sfmt 4703
8501
9040
9600
9670
Schedule
II
II
II
II
regarding the items contained in this
notice, especially the estimated public
burden and associated response time,
should be directed to Mrs. Amy C.
Blasher, Unit Chief, Federal Bureau of
Investigation, CJIS Division, Module
E–3, 1000 Custer Hollow Road,
Clarksburg, West Virginia 26306;
facsimile (304) 625–3566. Written
comments and/or suggestions can also
be sent to the Office of Management and
Budget, Office of Information and
Regulatory Affairs, Attention
Department of Justice Desk Officer,
Washington, DC 20503 or sent to OIRA_
submissions@omb.eop.gov.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection:
(1) Type of Information Collection:
Extension with change, of a currently
approved collection.
(2) Title of the Form/Collection:
National Incident-Based Reporting
System.
(3) Agency form number, if any, and
the applicable component of the
Department sponsoring the collection:
Agency form number: 1110–0058.
Sponsoring component: Department of
E:\FR\FM\19MYN1.SGM
19MYN1
]]>Agencies
[Federal Register Volume 82, Number 96 (Friday, May 19, 2017)]
[Notices]
[Pages 23071-23072]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-10242]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Mallinckrodt LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.34(a) on or before June 19, 2017. Such persons may also file a
written request for a hearing on the application pursuant to 21 CFR
1301.43 on or before June 19, 2017.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive,
Springfield, Virginia 22152. Comments and requests for hearing on
applications to import narcotic raw material are not appropriate. 72 FR
3417 (January 25, 2007).
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispenses, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on
December 21, 2016, Mallinckrodt LLC, 3600 North Second Street, Saint
Louis, Missouri 63147 applied to be registered as an importer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Marihuana.......................... 7360 I
[[Page 23072]]
Phenylacetone...................... 8501 II
Coca Leaves........................ 9040 II
Opium, raw......................... 9600 II
Poppy Straw Concentrate............ 9670 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
bulk manufacture into Active Pharmaceutical Ingredients for
distribution to its customers. Placement of these drug codes onto the
company's registration does not translate into automatic approval of
subsequent permit applications to import controlled substances.
In reference to drug code 7360 (Marihuana) the company plans to
import a synthetic cannabidiol. No other activity for this drug code is
authorized for this registration.
Dated: May 15, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017-10242 Filed 5-18-17; 8:45 am]
BILLING CODE P
